The independent source for health policy research, polling, and news.
1,281 - 1,299 of 1,299 Results
In an analysis published Monday in JAMA Internal Medicine, researchers found that text message reminders help patients do better when it comes to taking their medicines. But questions about the specific ways to make the most of this strategy remain.
Heated battle expected over November ballot proposal to curb state’s prescription drug costs, as pharmaceutical industry opens its pocketbook to defeat the measure.
Experimental drugs might help desperate patients, but don’t count on an easy cure.
As presidential candidates, state officials and even President Barack Obama wrestle with how to handle drug addiction, scientists lay out some of the intersections between opioid prescriptions and heroin abuse in the New England Journal of Medicine, including findings that crackdowns on opioid prescriptions may not fuel increases in heroin use.
Some medicines, particularly intravenous treatments, are not listed in plans’ pharmacy benefit section and, therefore, it’s difficult to confirm coverage specifics.
A research letter published Monday in JAMA Internal Medicine says opioid-prescribing practices are consistent with that of other medications.
Treating Hep C is expensive, but new drugs can quickly cure the disease, ultimately saving money.
A new Kaiser Family Foundation tracking poll reports 16 percent say they know someone who died from a prescription painkiller overdose.
The number of Medicare plans that cover medications with a subsidy provided for low-income beneficiaries is declining in 2016 by 20 percent.
The advocacy arm of the American Cancer Society said Wednesday that federal and state governments should move to restrict insurers from charging patients a percentage of the cost of their prescription drugs.
Only 16 percent of the popular plans cover all 10 of the most common drug regimens and charge less than $100 a month in consumer cost sharing, according to a report by Avalere Health.
Because of the complexity of insurance available through healthcare.gov and state exchanges, and the broad variation in how prescription drugs are covered, experts encourage consumers to compare options to figure out which one best fits their needs.
Nearly eight in 10 say they have seen or heard these ads, and more than a quarter have discussed one of the drugs with a physician as a result.
For beneficiaries, staying in their current plans could prove costly so advocates urge them to check out the alternatives.
Lawmakers, insurers and others have floated proposals to combat the spike in prescription drug prices, but will any of them gain traction?
Enrollment for private Medicare Advantage and Part D drug plans begins Oct. 15 and consumer advocates urge seniors to check out prices to find the best deals.
To control costs, the nation's largest pharmacy benefits manager has in place strict rules on which patients will be eligible.
The Democratic president candidate’s proposals to save consumers money are questioned by experts and health industry officials.
In an analysis, the Institute for Clinical and Economic Review concluded that price cuts are needed to control the budgetary impact.
© 2026 KFF